Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.

Authors:
Address: Infectious Diseases Group, Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK. tanya.parkinson@pfizer.com
Journal:

Publication:

abstract

There are currently no specific treatments for infection with Dengue virus (DENV) and West Nile Virus (WNV). drug-discovery programs are underway for both viruses, but as yet no Small molecules have advanced to clinical trials. hepatitis C virus (HCV) is a related flavivirus that has been the focus of intense drug discovery efforts for the last two decades. Many approaches currently being pursued for DENV and WNV have been previously attempted for HCV with varying degrees of success. The experience with HCV may direct DENV and WNV efforts towards approaches with the best chance of success. Based on experience with HCV, the viral polymerase and protease are attractive targets to focus on since these have been most successful to date. Cell-based phenotypic screening may also yield attractive inhibitors. The helicase and methyltransferase enzymes are likely to prove difficult targets and host target approaches are fraught with safety concerns.

Related Articles
Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
Antivir Chem Chemother. 2011
Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
Cregar-Hernandez L, Jiao GS, Johnson AT, Lehrer AT, Wong TA, Margosiak SA. Antivir Chem Chemother. 2011 May 12; 21(5):209-17. Epub 2011 May 12.
Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
Bioorg Med Chem. 2011
Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
Nitsche C, Steuer C, Klein CD. Bioorg Med Chem. 2011 Dec 15; 19(24):7318-37. Epub 2011 Oct 25.
Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives.
Bioorg Med Chem. 2012
Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives.
Tiew KC, Dou D, Teramoto T, Lai H, Alliston KR, Lushington GH, Padmanabhan R, Groutas WC. Bioorg Med Chem. 2012 Feb 1; 20(3):1213-21. Epub 2011 Dec 30.
Review Strategies for development of Dengue virus inhibitors.
Antiviral Res. 2010
Review Strategies for development of Dengue virus inhibitors.
Noble CG, Chen YL, Dong H, Gu F, Lim SP, Schul W, Wang QY, Shi PY. Antiviral Res. 2010 Mar; 85(3):450-62. Epub 2010 Jan 8.
Review West Nile Virus NS2B/NS3 protease as an antiviral target.
Curr Med Chem. 2008
Review West Nile Virus NS2B/NS3 protease as an antiviral target.
Chappell KJ, Stoermer MJ, Fairlie DP, Young PR. Curr Med Chem. 2008; 15(27):2771-84.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.